Andrew Saik
2020 - VYNE Therapeutics
In 2020, Andrew Saik earned a total compensation of $1.5M as Chief Financial Officer and Treasurer at VYNE Therapeutics.
Compensation breakdown
| Bonus | $112,500 |
|---|---|
| Option Awards | $470,315 |
| Salary | $309,722 |
| Stock Awards | $644,000 |
| Total | $1,536,537 |
Saik received $644K in stock awards, accounting for 42% of the total pay in 2020.
Saik also received $112.5K in bonus, $470.3K in option awards and $309.7K in salary.
Rankings
In 2020, Andrew Saik's compensation ranked 6,731st out of 13,090 executives tracked by ExecPay. In other words, Saik earned more than 48.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,731 out of 13,090 | 49th |
Division Manufacturing | 2,802 out of 5,620 | 50th |
Major group Chemicals And Allied Products | 1,131 out of 2,253 | 50th |
Industry group Drugs | 975 out of 1,953 | 50th |
Industry Pharmaceutical Preparations | 728 out of 1,458 | 50th |
Source: SEC filing on June 7, 2021.
Saik's colleagues
We found three more compensation records of executives who worked with Andrew Saik at VYNE Therapeutics in 2020.